Host genetic polymorphisms in human immunodeficiency virus-related neurologic disease

Journal of NeuroVirology

Volumn 10, Issue SUPPL. 1, 2004, Pages 67-73

  Diaz Arrastia, Ramon ^a   Gong, Yunhua ^a   Kelly, Cynthia J ^a   Gelman, Benjamin B ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Apolipoprotein E; Interleukin 1; Tumor necrosis factor

Indexed keywords

APOLIPOPROTEIN E4; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLELE; ARTICLE; BRAIN TISSUE; CAUSE OF DEATH; CONTROLLED STUDY; DNA EXTRACTION; ENCEPHALITIS; GENERAL PATHOLOGY; GENETIC POLYMORPHISM; GENOTYPE; GIANT CELL; HISTOPATHOLOGY; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INFECTION RESISTANCE; INFECTION RISK; INFECTION SENSITIVITY; INHERITANCE; MAJOR CLINICAL STUDY; MICROGLIA; MYELIN DEFICIENCY; NERVE DEGENERATION; NEUROLOGIC DISEASE; NEUROLOGICAL COMPLICATION; NEUROPATHOLOGY; PATHOGENESIS; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SAMPLE SIZE; SPINAL CORD DISEASE; TISSUE SECTION;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 1542285313     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/753312755     Document Type: Article

References (42)

1. Bioque G, Crusius JBA, Koutroubakis I, Bouma G, Kostense PJ, Meuwissen SGM, Pena AS (1995). Allelic polymorphism in IL-1beta and IL-1 receptor antagonist (IL-1Ra) genes ininflammatory bowel disease. Clin Exp Immunol 102: 379-383.
2. Blakemore AIF, Tarlow JK, Cork MJ, Gordon C, Emery P, Duff GW (1994). Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum 37: 1380-1385.
3. Chapman J, Estupinan J, Asherov A, Goldfarb LG (1996). A simple and efficient method for apolipoprotein E genotype determination. Neurology 46: 1484-1485.
4. Chapman J, Vinokurov S, Achiron A, Karussis DM, Mitosek-Szewcyk K, Birnbau M, Michaelson DM, Korczyn AD (2001). APOE genotype is a major predictor of long-term progression of disability in MS. Neurology 56: 312-316.
5. Cherner M, Masliah E, Ellis RJ, Marcotte TD, Moore DJ, Grant I, Heaton RK (2002). Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis. Neurology 59: 1563-1567.
6. Childs EA, Lyles RH, Selnes OA, Chen B, Miller EN, Cohen BA, Becker JT, Mellors J, McArthur JC (1999). Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology 52: 607-613.
7. Corder EH, Robertson K, Lannfelt L, Bogdanovic N, Eggertsen G, Wilkins J, Hall C (1998). HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nat Med 4: 1182-1184.
8. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923.
9. Crucius JBA, Pena AS, van Osten BW, Bioque G, Garcia A, Dijkstra CD, Polman CH (1995). Interleukin-1 receptor antagonist gene polymorphism and multiple sclerosis. Lancet 346: 979-980.
10. Danis VA, Millington M, Hyland VJ, Grennan D (1995). Cytokine production by normal humanmonocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 99: 303-310.
11. de la Concha EG, Arroyo R, Crusius JBA, Campillo JA, Martin C, Varela de Seijas E, Pena AS, Claveria LE, Femandez-Arquero M (1997). Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist allele 2 in susceptibility to relapsing-remitting multiple sclerosis. J Neuroimmunol 80: 172-178.
12. Dunlop O, Goplen AK, Liestol K, Myrvang B, Rootwelt H, Christopherson B, Kvittingen E-A, Maelen J (1997). HIV dementia and apolipoprotein E. Acta Neurol Scand 95: 315-318.
13. Emahazion T, Jobs M, Howell WM, Siegfried M, Wyoni P-I, Prince JA, Brookes AJ (1999). Identification of 167 polymorphisms in 88 genes from candidate neurodegeneration pathways. Gene 238: 315-324.
14. Fazekas F, Strasser-Fuchs S, Kollegger H, Berger T, Kristoferitsch W, Schmidt H, Enzinger C, Schifermeier M, Schwarz C, Kornek B, Reindl M, Huber K, Wimmer G, Vass K, Pfeiffer KH, Hartung HP, Schmidt R (2001). Apolipoprotein E4 is associated with rapid progression of multiple sclerosis. Neurology 57: 853-857.
15. Friedman G, Froom P, Sazbon L, Grinblatt I, Shochina M, Tsenter J, Babaey S, Ben Yehuda A, Groswasser Z (1999). Apolipoprotein E-epsilon4 genotype predicts a poor outcome insurvivors of traumatic brain injury. Neurology 52: 244-248.
16. Gelman BB, Dholakia S, Casper K, Kent TA, Cloyd MW, Freeman D (1996). Expansion of the cerebral ventricles and correlation with acquired immunodeficiency syndrome neuropathology in 232 patients. Arch Pathol Lab Med 120: 866-871.
17. Goldstein DB (2001). Islands of linkage disequilibrium. Nat Genet 29: 109-111.
18. Griffin DE (1997). Cytokines in the brain during viral infection: clues to HIV-associated dementia. J Clin Invest 100: 2948-2951.
19. Huang S-L, Su C-H, Chang S-C (1997). Tumor necrosis factor-alpha gene polymorphism in chronic bronchitis. Am J Respir Crit Care Med 156: 1436-1439.
20. Jordan BD, Relkin NR, Ravdin LD, Jacobs AR, Bennett A, Gandy S (1997). Apolipoprotein E E4 associated with chronic traumatic brain injury in boxing. J Am Med Asso 278: 136-140.
21. Lander ES, Kruglyak L (1995). Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11: 241-247.
22. Lipton SA (1998). Neuronal injury associated with HIV-1: approaches to treatment. Ann Rev Pharmacol Toxicol 38: 159-177.
23. Lucotte G, Loirat F, Hazout S (1997). Pattern of gradient of apolipoprotein E allele *4 frequencies in Western Europe. Hum Biol 69: 253-262.
24. Mansfield JC, Holden H, Tarlow JK, Francesco S, Glovine D, McDowell DL, Wilson AG (1994). Novel genetic association between ulcerative colitis and the antiinflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 106: 637-642.
25. Mayeux R, Stern Y, Ottman R, et al (1993). The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. Ann Neurol 34: 752-754.
26. McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwiatkowski D (1994). Variation of the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 371: 508-511.
27. Monforte AD, Duca PG, Vago L, Grassi MP, Moroni M (2000). Decreasing incidence of CNS AIDS-defining events associated with antiretroviral therapy. Neurology 54: 1856-1859.
28. Mrak RE, Griffin WST (1997). The role of chronic self-propagating glial responses in neurogeneration: implications for long-lived survivors of human immunodeficiency virus. J NeuroVirol 3: 241-246.
29. Nadel S, Newport MJ, Booy R, Levin M (1996). Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J Infect Dis 174: 878-880.
30. Perrier S, Coussediere C, Dubost JJ, Albuisson E, Sauvezie B (1998). IL-1 receptor antagonist (IL-1RA) gene polymorphism in Sjogren's syndrome and rheumatoid arthritis. Clin Immunol Immunopathol 87: 309-313.
31. Plomin R, McClearn GE, Smith DL, Vignetti S, Chorney MJ, Chorney K, Vanditti CP, Kasarda S, Thompson LA, Detterman DK, Daniels J, Owen M, McGuffin P (1994). DNA markers associated with high versus low IQ: the IQ quantitative trait loci (QTL) project. Behav Genet 24: 107-118.
32. Pociot F, Molving J, Wogensen L, et al (1992). TaqI polymorphism in the human interleukin-1β gene correlates with IL-1 beta secretion in vitro. Eur J Clin Inves 22: 396-402.
33. Quasney MW, Zhang Q, Sargent S, Mynatt M, Glass J, McArthur JC (2001). Increased frequency of the tumor necrosis factor-α -308 A allele in adults with human immunodeficiency virus dementia. Ann Neurol 50: 157-162.
34. Risch N, Merikangas K (1996). The future of genetic studies of complex human diseases. Science 273: 1516-1517.
35. Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, Becker JT, Cohen BA, McArthur JC (2001). HIV-associated neurologic disease incidence changes: multicenter AIDS cohort study, 1990-1998. Neurology 56: 257-260.
36. Sato-Matsumura K, Berger J, Hainfellner JA, Mazal P, Budka H (1998). Development of HIV-encephalitis in AIDS and TNF-α regulatory elements. J Neuroimmunol 91: 89-92.
37. Simpson DM (1999). Human immunodeficiency virus-associated dementia: review of pathogenesis, prophylaxis, and treatment studies of zidovudine therapy. Clin Infect Dis 29: 19-34.
38. Swindells S, Zheng J, Gendelman HE (1999). HIV-associated dementia: new insights into disease pathogenesis and therapeutic interventions. AIDS Patient Care STDs 13: 153-163.
39. Tang MX, Maestre G, Tsai WY, Liu XH, Feng L, Chung WY, Chun M, Schofield P, Stern Y, Tycko B, Mayeux R (1996). Relative risks of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City. Am J Hum Genet 58: 574-584.
40. Teasdale GM, Nicoll JAR, Murray G, Fiddes M (1997). Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 350: 1069-1071.
41. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW (1997). Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 94: 3195-3199.
42. Zink WE, Zheng J, Persidsky Y, Poluektova L, Gendelman HE (1999). The neuropathogenesis of HIV-1 infection. FEMS Immunol Med Microbiol 26: 233-241.